Trends & Analysis
Global Antibody Drug Industry Development Blue Book (Frost & Sullivan)
This Frost & Sullivan 2026 Blue Book provides a comprehensive analysis of the global and Chinese antibody therapeutics industry. It covers market scale, technology evolution, and supply chain localization, highlighting key enablers like Cyagen to offer strategic guidance for stakeholders.
Overview
The global antibody drug market is experiencing robust expansion, driven by clinical demand and structural upgrades toward modalities like bispecific antibodies and ADCs. Simultaneously, China's antibody industry is entering a high-growth phase, fueled by favorable policies, international expansion, and supply chain localization. The integration of AI-assisted design and advanced discovery platforms—such as Cyagen’s fully humanized mouse models and CRO services—is significantly accelerating R&D efficiency. These upstream innovations empower the midstream and downstream sectors to push toward more complex, multi-mechanism therapies, heavily focused on addressing high-burden malignancies.
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
- Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
- Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
- Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
- Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.